Starting 1 January 2026, full members of the Société Française de Radiothérapie Oncologique (SFRO) will benefit from a joint SFRO - ESTRO (membership for a single annual fee of €140.
This initiative represents a major milestone in strengthening the ties between the two societies and reflects their shared commitment to advancing radiotherapy and oncology, both in France and across Europe.

 

One membership, two societies, twice the benefits

Through this joint formula, members will gain full access to the combined advantages of the SFRO and the ESTRO, with no additional administrative steps.

On the SFRO side, members will continue to enjoy:
• Scientific and educational resources, including Recorad in digital format, an online library, webinars, and thematic guides;

• The Cancer Radiothérapie journal, which will be published in English starting January 2026 (new), expanding its international reach;

• And preferential rates for the annual SFRO congress, a highlight of the French-speaking scientific community.

On the ESTRO side, membership provides access to:
• The Radiotherapy & Oncology journal in digital format;
• The ESTRO e-Library, bringing together courses, presentations, and conference materials;
• Discounted registration rates for congresses and teaching courses;
• And the opportunity to participate in ESTRO’s working groups, committees, and governing bodies.

 

A partnership dedicated to knowledge sharing and training

This collaboration — a historic first for both societies — demonstrates a shared ambition: to facilitate the exchange of knowledge, promote continuous education, and strengthen the voice of French radiotherapy professionals within the broader European scientific community.

By joining forces, the SFRO and ESTRO aim to:
• Increase the international visibility of French research;
• Promote mobility and scientific collaboration among members;
• And harmonise European standards in education and clinical practice.

 

A simple and rewarding international connection

With a single registration, members gain access to two complementary networks—two sources of knowledge, connection, and opportunity.
This streamlined membership responds to a long-standing need: to combine national engagement and international openness, without added complexity or cost.

By working together, the SFRO and ESTRO are laying the foundation for a sustainable and forward-looking partnership that will shape the radiotherapy of tomorrow.
This initiative reflects a shared vision: that of a united, open, and ambitious scientific community, driven by innovation and excellence in the service of patients.

One membership, two societies, twice the opportunities — for stronger radiotherapy in France and across Europe.